Zurich Cantonal Bank
LAB icon

Zurich Cantonal Bank’s Standard BioTools LAB Stock Holding History

Zurich Cantonal Bank’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,330
Closed -$46.3K – 2584
2026
Q1 		$46.3K Hold
50,330
– – ﹤0.01% 2444
2025
Q4 		$64.4K Hold
50,330
– – ﹤0.01% 2430
2025
Q3 		$65.4K Hold
50,330
– – ﹤0.01% 2428
2025
Q2 		$60.4K Hold
50,330
– – ﹤0.01% 2450
2025
Q1 		$54.4K Hold
50,330
– – ﹤0.01% 2506
2024
Q4 		$88.1K Hold
50,330
– – ﹤0.01% 2468
2024
Q3 		$97.1K Hold
50,330
– – ﹤0.01% 2429
2024
Q2 		$89.1K Buy
50,330
+32,640
+185% +$79.8K ﹤0.01% 2423
2024
Q1 		$47.9K Buy
+17,690
New +$42.7K ﹤0.01% 2568
2022
Q2 		– Sell
-13,580
Closed -$49K – 2914
2022
Q1 		$49K Hold
13,580
– – ﹤0.01% 2528
2021
Q4 		$53K Hold
13,580
– – ﹤0.01% 2716
2021
Q3 		$89K Hold
13,580
– – ﹤0.01% 2400
2021
Q2 		$84K Hold
13,580
– – ﹤0.01% 2289
2021
Q1 		$61K Hold
13,580
– – ﹤0.01% 2335
2020
Q4 		$81K Buy
+13,580
New +$89.2K ﹤0.01% 2299
2020
Q2 		– Sell
-5,533
Closed -$14K – 2567
2020
Q1 		$14K Hold
5,533
– – ﹤0.01% 2428
2019
Q4 		$19K Hold
5,533
– – ﹤0.01% 2513
2019
Q3 		$26K Hold
5,533
– – ﹤0.01% 2365
2019
Q2 		$68K Buy
+5,533
New +$70.5K ﹤0.01% 1870
2016
Q4 		– Sell
-396
Closed -$3K – 2567
2016
Q3 		$3K Hold
396
– – ﹤0.01% 2542
2016
Q2 		$4K Hold
396
– – ﹤0.01% 2514
2016
Q1 		$3K Hold
396
– – ﹤0.01% 2544
2015
Q4 		$4K Hold
396
– – ﹤0.01% 2533
2015
Q3 		$3K Buy
396
+263
+198% +$4.14K ﹤0.01% 2434
2015
Q2 		$3K Hold
133
– – ﹤0.01% 2127
2015
Q1 		$6K Buy
+133
New +$5.26K ﹤0.01% 1732

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Zurich Cantonal Bank's LAB Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 50,330 shares — an estimated $46.3K sold.

Zurich Cantonal Bank first reported a position in LAB in Q1 2015 and held it in 26 quarters. The position peaked at $97.1K in Q3 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Zurich Cantonal Bank reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Zurich Cantonal Bank sold 50,330 Standard BioTools shares in Q2 2026, an estimated $46.3K.
  • Zurich Cantonal Bank first reported a position in Standard BioTools in Q1 2015 and held it in 26 quarters.
  • Zurich Cantonal Bank's Standard BioTools position peaked at $97.1K in Q3 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.